In an interview to CNBC-TV18, Manish Kiri, MD of Kiri Industries said that the company expect revenue of Rs 1,100-1,200 crore by year end.
In a discussion on CNBC-TV18, Manish Kiri, MD of Kiri Industries and Ankit Patel, ED of Bodal Chemicals outlined price trend of Vinyl Sulphone in the Indian market and how it has impacted their company's revenue.
The company has no capex plans in the near-term, but aims to utilise its capacities to their fullest by increasing production of dyes, says Manish Kiri, the MD of Kiri Industries, in an interview to CNBC-TV18.
Speaking to CNBC-TV18, Manish Kiri, MD of Kiri Industries said that the company expects revenue to be around Rs 1000 crore and sees FY17 revenue to be in the range of Rs 1200-1300 crore if the price hike stays for a minimum of 6 months.
Manish Kiri, managing director (MD) of Kiri Industries in an interview to CNBC-TV18 said, news about acquisition of Single Super Phosphate (SSP) facility of Bodal Chemicals is false.
Manish Kiri, MD of Kiri Dyes, in an interview with CNBC-TV18’s Reema Tendulkar and Ekta Batra, expects Dystar’s listing to take place in either middle or late of 2012 of calendar year. He said, "We are looking at around 10-15 PE multiple and an expected profit line of around 60-70 million euro after tax."